Important Safety Considerations Cardiovascular Risks : Average increase in heart rate: 5-10 bpm Blood pressure elevation: 5-10 mmHg systolic Contraindicated in patients with structural cardiac abnormalities Neuropsychiatric Effects : Risk of anxiety, insomnia, and irritability Potential for exacerbating tic disorders Rare cases of psychosis at high doses The Reality of Off-Label Use for Weight Loss While some providers prescribe Adderall off-label for weight management, several concerns exist: Lack of Long-Term Data : No studies support its efficacy beyond 6 months for weight loss
In December 2025, WW launched a standalone GLP-1 Success program for members whose prescriptions come from outside providers, positioning the company as the support layer around GLP-1s regardless of where the script originates
No pancreatic safety concern following glucagon-like peptide-1 receptor agonist therapies: a pooled analysis of cardiovascular outcome trials
Ultimately, 19 studies were included in this systematic review, comprising 11 RCTs and 8 observational studies (Fig
however, recent experimental animal studies suggested that GLP-2 exerts beneficial effects on glucose metabolism in conditions related to increased uptake of energy, such as obesity
1994;Sep:46572